Lawmakers say middlemen in the prescription drug pipeline are limiting access to medications. It’s gotten the attention of both sides of the aisle, but reforms are stalled in Congress.
Related Posts
-
Inflation remains elevated as affordability concerns grow
Inflation continues to rise, with prices increasing by 0.3% in December and 2.7% over the…
-
Trump administration ends temporary protected status for Somali immigrants
Temporary protected status is provided to immigrants from some countries facing safety conditions, such as…
-
DHS to invest $115 million in counter-drone tech ahead of World Cup
The announcement comes as drug cartels are increasing their technological sophistication, having used their own…
-
Clintons refuse to testify in House Epstein investigation as Republicans threaten contempt charges
The Clintons say they will refuse to comply with a congressional subpoena for them to…
Leave a Reply